Finished
Safety and Usability of the STELO Exoskeleton in People With Acquired Brain Injury and Spinal Cord Injury
NCT05265377 · MarsiBionics · Updated 22 May 2023
- What is being tested
- Stelo
- For
- Spinal Cord Injury; Acquired Brain Injury
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 20 people. The full rules are on the registry page.
- Where
- Spain (3 sites)
- When
- Starts or started 21 Sept 2022, ends 30 April 2023. Registered 3 March 2022.
- Results
- None posted yet.
In the researchers' words
Gait impairment in people with acquired brain injury (ABI) and spinal cord injury (SCI) can be very heterogeneous. For this reason, STELO has been developed: a new concept of exoskeleton based on modular technology for gait assistance. It allows a personalised configuration according to the functional capacity of each patient, as the therapist can choose which robotic joints to use depending on the therapeutic goal and on the patient recovery phase. The objective is to analyse the usability of the STELO modular exoskeleton in people with ABI and SCI.
Sites
- CEADACMadrid, Spain
- Centre for Automation and RoboticsMadrid, Spain
- LESCERMadrid, Spain